PACAP 6-38
Tocris Bioscience | Catalog # 3236
Key Product Details
Description
Product Description
PACAP 6-38 is a potent and competitive pituitary adenylate cyclase-activating polypeptide receptor (PAC)1 antagonist (IC50 = 2 nM). Inhibits PACAP(1-27)-induced stimulation of adenylate cyclase (Ki = 1.5 nM). Antitumor activity in vivo.
Product Specifications for PACAP 6-38
Molecular Weight
Formula
Storage
Purity
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solubility | Soluble to 2mg/ml in water |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 22 publications citing the usage of this product.
- Leyton PACAP(6-38) inhibits growth of prostate cancer cells. Cancer Lett. 1998 PMID: 9566707
- Kojro The neuropeptide PACAP promotes a-secretase pathway for processing Alzheimer amyloid precursor protein. FASEB J. 2006 PMID: 16401644
- Robberecht Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur.J.Biochem. 1992 PMID: 1321043
Product Documents for PACAP 6-38
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for PACAP 6-38
For research use only
Citations for PACAP 6-38
Customer Reviews for PACAP 6-38
There are currently no reviews for this product. Be the first to review PACAP 6-38 and earn rewards!
Have you used PACAP 6-38?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review